NM_001409301.1:c.-18+1332_-18+1333delGG
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_001409301.1(NSD1):c.-18+1332_-18+1333delGG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Consequence
NSD1
NM_001409301.1 intron
NM_001409301.1 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.20
Publications
0 publications found
Genes affected
NSD1 (HGNC:14234): (nuclear receptor binding SET domain protein 1) This gene encodes a protein containing a SET domain, 2 LXXLL motifs, 3 nuclear translocation signals (NLSs), 4 plant homeodomain (PHD) finger regions, and a proline-rich region. The encoded protein enhances androgen receptor (AR) transactivation, and this enhancement can be increased further in the presence of other androgen receptor associated coregulators. This protein may act as a nucleus-localized, basic transcriptional factor and also as a bifunctional transcriptional regulator. Mutations of this gene have been associated with Sotos syndrome and Weaver syndrome. One version of childhood acute myeloid leukemia is the result of a cryptic translocation with the breakpoints occurring within nuclear receptor-binding Su-var, enhancer of zeste, and trithorax domain protein 1 on chromosome 5 and nucleoporin, 98-kd on chromosome 11. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Sep 2018]
NSD1 Gene-Disease associations (from GenCC):
- Beckwith-Wiedemann syndrome due to NSD1 mutationInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Sotos syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
- Sotos syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NSD1 | NM_001409301.1 | c.-18+1332_-18+1333delGG | intron_variant | Intron 1 of 22 | NP_001396230.1 | |||
NSD1 | NM_001409302.1 | c.-18+112_-18+113delGG | intron_variant | Intron 1 of 22 | NP_001396231.1 | |||
NSD1 | NM_001409304.1 | c.-18+1332_-18+1333delGG | intron_variant | Intron 1 of 23 | NP_001396233.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NSD1 | ENST00000354179.9 | c.-151+111_-151+112delGG | intron_variant | Intron 1 of 23 | 5 | ENSP00000346111.5 | ||||
NSD1 | ENST00000508896.7 | c.-151+1331_-151+1332delGG | intron_variant | Intron 1 of 23 | 3 | ENSP00000423372.3 | ||||
NSD1 | ENST00000689549.1 | n.130+111_130+112delGG | intron_variant | Intron 1 of 19 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Sotos syndrome Uncertain:1
May 28, 2019
Mendelics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.